Literature DB >> 28392190

Prevalence, Patterns, and Predictors of Depression Treatment among Community-Dwelling Elderly Individuals with Dementia in the United States.

Sandipan Bhattacharjee1, Yeum Mok Oh2, Eric M Reiman3, William J Burke4.   

Abstract

OBJECTIVES: Co-occurring dementia and depression exerts a substantial burden on the elderly. This study utilizes data from a nationally representative cohort of community-dwelling individuals 65 years and older to examine the prevalence, patterns, and predictors of depression treatment among elderly individuals with co-occurring dementia and depression.
DESIGN: Retrospective, cross-sectional study.
SETTING: Multiple years of Medical Expenditure Panel Survey (2002, 2004, 2006, 2008, 2010, and 2012) data. PARTICIPANTS: The study sample consisted of elderly (age ≥65 years) individuals who 1) had dementia, 2) were alive during the calendar year, and 3) had co-occurring depression. MEASUREMENTS: The dependent variable of this study was depression treatment, identified by antidepressant medication with or without psychotherapy use. Individual level factors associated with depression treatment among elderly individuals with dementia and co-occurring depression were evaluated by conducting multinomial logistic regression.
RESULTS: Co-occurring depression prevalence among community-dwelling elderly individuals with dementia was approximately 22%. An overwhelming majority (nearly 88%) of the study sample reported receipt of depression treatment. Antidepressants only and combination therapy (antidepressant with psychotherapy) was reported by 75% and 13%, respectively, of the study sample. Age, race/ethnicity, marital status, limitations of instrumental activities of daily living, perceived mental health status, and pain were significantly associated with the reporting of receipt of depression treatment.
CONCLUSIONS: An overwhelming majority of the study sample received depression treatment and several subgroup differences (such as in terms of age) existed in terms of reporting the use of depression treatment was observed.
Copyright © 2017 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; antidepressants; depression; psychotherapy

Mesh:

Substances:

Year:  2017        PMID: 28392190     DOI: 10.1016/j.jagp.2017.03.003

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  7 in total

1.  Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Authors:  Ariel R Green; Liza M Reifler; Cynthia M Boyd; Linda A Weffald; Elizabeth A Bayliss
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

2.  Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder.

Authors:  Sandipan Bhattacharjee; Jeannie K Lee; Asad E Patanwala; Nina Vadiei; Daniel C Malone; Shannon M Knapp; Wei-Hsuan Lo-Ciganic; William J Burke
Journal:  Am J Geriatr Psychiatry       Date:  2019-02-07       Impact factor: 4.105

Review 3.  Mental Health Issues in Racial and Ethnic Minority Elderly.

Authors:  Nhi-Ha T Trinh; Richard Bernard-Negron; Iqbal Ike Ahmed
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

4.  Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study.

Authors:  Sandipan Bhattacharjee; Majed Al Yami; Sawsan Kurdi; David Rhys Axon
Journal:  BMC Psychiatry       Date:  2018-05-16       Impact factor: 3.630

5.  Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder.

Authors:  Sandipan Bhattacharjee; Jeannie K Lee; Nina Vadiei; Asad E Patanwala; Daniel C Malone; Shannon M Knapp; Wei-Hsuan Lo-Ciganic; William J Burke
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-08       Impact factor: 2.570

6.  Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States.

Authors:  Omar A Almohammed; Abdulaziz A Alsalem; Abdullah A Almangour; Lama H Alotaibi; Majed S Al Yami; Leanne Lai
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.240

7.  Clinically relevant drug-drug interactions among elderly people with dementia.

Authors:  Eva Sönnerstam; Maria Sjölander; Hugo Lövheim; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2018-07-02       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.